Phase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors

Published:2010-09-16 Issue:10 Volume:51 Page:1524-1531
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Menda Yusuf,O'Dorisio M. Sue,Kao Simon,Khanna Geetika,Michael Stacy,Connolly Mary,Babich John,O'Dorisio Thomas,Bushnell David,Madsen Mark

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference36 articles.

1. High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy;Fruhwald;Pediatr Res.,1999

2. Somatostatin receptor gene expression in neuroblastoma

3. Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

4. Somatostatin receptor imaging for neuroendocrine tumors

5. MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use;Pashankar;J Nucl Med.,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

2. Safety and Efficacy of 177Lu-DOTATATE in Children and Young Adult Population;Clinical Nuclear Medicine;2024-05-21

3. Case report: Peptide receptor radioligand therapy in metastatic pediatric neuroendocrine tumors;Frontiers in Nuclear Medicine;2023-08-03

4. Peptide receptor radionuclide therapy in neuroendocrine neoplasms and related tumors: from fundamentals to personalization and the newer experimental approaches;Expert Review of Precision Medicine and Drug Development;2023-05-17

5. Pediatric Neuroendocrine Neoplasms: Rare Malignancies with Incredible Variability;Cancers;2022-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3